Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
brivaracetam (formerly Rikelta)
Also known as: UCB 34714
print preview
bookmark
share with colleague
General Information
Company
UCB Group
Description
High affinity synaptic vesicle protein (SV2A) ligand
Molecular Target
Synaptic vesicle protein (SV2A)
Mechanism of Action
Latest Stage of Development
Phase III
Indication
Seizures
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy